DSNKY (DSNKY) Stock Price & Analysis
DSNKY (DSNKY) fell 0.62% to USD 15.93 as of June 9, 2026 at 23:55 UTC, according to Nexqual real-time market data.
DSNKY last closed at USD 16.03; the session ranged USD 15.84–16.06 on volume of 35,552 shares. Market capitalization is $28.99B, with a 52-week range of USD 14.98–27.5 (PNK). Source: Nexqual, June 9, 2026 at 23:55 UTC.
Key Statistics (as of June 9, 2026 at 23:55 UTC)
| Price | USD 15.93 |
|---|---|
| Change | ▼ 0.62% (down) |
| Previous Close | USD 16.03 |
| Open | USD 16.05 |
| Day Range | USD 15.84 – 16.06 |
| 52-Week Range | USD 14.98 – 27.5 |
| Volume | 35,552 shares |
| Market Cap | $28.99B |
| Exchange | PNK |
Technical Analysis (DSNKY)
Nexqual's technical model rates DSNKY "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 9, 2026 at 23:55 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 42.15 (neutral) |
| vs SMA50 | Below (USD 16.99) |
| MACD | -0.37 (negative) |
Analyst Ratings (DSNKY)
Wall Street analysts rate DSNKY "None" based on 2 analysts, with a mean price target of USD 25.5 (range USD 22–29), per Nexqual as of June 9, 2026 at 23:55 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 25.5 |
| High Target | USD 29 |
| Low Target | USD 22 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (DSNKY)
| Next Earnings Date | 2026-07-30 |
|---|---|
| Revenue Estimate | $531.33B |
Source: Nexqual, June 9, 2026 at 23:55 UTC.
Financials & Fundamentals (DSNKY)
| Total Revenue | $2.12T |
|---|---|
| Revenue Growth (YoY) | +13.70% |
| Gross Margin | +68.49% |
| Operating Margin | -0.80% |
| Profit Margin | +12.24% |
| ROE | +15.81% |
| Debt / Equity | 18.06 |
| Current Ratio | 2.42 |
| Total Cash | $449.81B |
| Total Debt | $300.48B |
| Free Cash Flow | $-225.47B |
Source: Nexqual, June 9, 2026 at 23:55 UTC.
Financial Health Score (DSNKY)
Nexqual rates DSNKY's overall financial health "Solid" across five dimensions, as of June 9, 2026 at 23:55 UTC.
| Growth | Solid — Revenue +13% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 68%, operating -1% |
| Balance Sheet | Strong — $449.8B cash vs $300.5B debt, net cash position |
| Cash Flow | Weak — FCF negative: -$225.5B, burning cash |
| Efficiency | Solid — ROE 16%, ROA 3.8% |
Ownership (DSNKY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.03% |
| Shares Outstanding | 1.82B |
| Float | 1.82B |
Source: Nexqual, June 9, 2026 at 23:55 UTC.
Leadership (DSNKY)
DSNKY is led by Hiroyuki Okuzawa (age 63), President, CEO & Representative Director, per Nexqual as of June 9, 2026 at 23:55 UTC.
| President, CEO & Representative Director | Hiroyuki Okuzawa (age 63) |
|---|---|
| Senior Executive Officer, Head of Global Corporate Planning & Management and CFO | Tomohiro Kodama |
| Corporate Officer, Head of Business Transformation & CTO | Tetsuya Ohira |
| Sr. Exec Ofcr, Chief Corp Affairs Ofcr, Head of Global Corp Affairs & HR, CHRO & Director | Takashi Matsumoto (age 61) |
| Head of Oncology Business Unit & Global Oncology Business and Director | Joseph Kenneth Keller (age 62) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
| DSKYF | Daiichi Sankyo Co., Ltd. | USD 14.96 | ▼ 2.09% |
| OTSKY | Otsuka Holdings Co. Ltd. | USD 31.86 | ▼ 2.03% |
| ALPMY | Astellas Pharma, Inc. | USD 13.3 | ▲ 0.53% |
| HOCPY | Hoya Corp. | USD 158.4 | ▼ 0.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:55 UTC. This page is informational and not investment advice.